Interactive Tools

Trending on OncLive

VGX-3100 Elicits Regression and Clearance in HPV-16/18–Associated Cervical HSILs

EVX-01 Plus Pembrolizumab Yields Neoantigen-Specific T-Cell Responses in Advanced Melanoma

Canakinumab Reduces Nodule Size in High-Risk Lung Precancers

IDP-023 Plus Isatuximab Drives Responses in Daratumumab-Refractory Multiple Myeloma

Dr Najjar on Data for the Oncolytic Virus VET3-TGI in Advanced Solid Tumors